Correlation Between CT Severity Scoring and Diabetes Mellitus in Patients With COVID-19 Infection
- PMID: 35004020
- PMCID: PMC8729062
- DOI: 10.7759/cureus.20199
Correlation Between CT Severity Scoring and Diabetes Mellitus in Patients With COVID-19 Infection
Abstract
Background and objective Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), was first identified in Wuhan, China in December 2019. Since then, It has spread across multiple countries and was declared a pandemic by WHO in March 2020. Patients with underlying diabetes mellitus (DM) are deemed at-risk for developing severe COVID-19 infection. In light of this, we aimed to evaluate the correlation between DM and chest CT severity scores (CTSS) in COVID-19 patients. Methods This was a hospital-based descriptive, analytical retrospective study conducted at our tertiary care hospital. A quantitative severity score was calculated among 220 patients with COVID-19 infection based on the degree of lung lobe involvement on CT chest scans. Based on CTSS, the patients were classified into groups of mild, moderate, and severe lung involvement. The association between DM and CTSS was evaluated using the chi-square test. Results The severity of lung involvement was higher among COVID-19 patients with a co-diagnosis of DM (29.3%) compared to those without DM (11.7%). This association of severe lung involvement with DM was statistically significant (p=0.002). Conclusion Based on our findings, diabetic patients are at an increased risk of developing the severe form of COVID-19 with a higher CT lung involvement score compared to non-diabetic patients.
Keywords: covid-19; ctss; diabetes; hrct; severe.
Copyright © 2021, Rangankar et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
Patients with Diabetes Experienced More Serious and Protracted Sickness from the COVID-19 Infection: A Prospective Study.Medicina (Kaunas). 2023 Feb 27;59(3):472. doi: 10.3390/medicina59030472. Medicina (Kaunas). 2023. PMID: 36984473 Free PMC article.
-
Comparison of semiquantitative chest CT scoring systems to estimate severity in coronavirus disease 2019 (COVID-19) pneumonia.Eur Radiol. 2022 May;32(5):3513-3524. doi: 10.1007/s00330-021-08435-2. Epub 2022 Jan 12. Eur Radiol. 2022. PMID: 35020014 Free PMC article.
-
Assessing the Impact of Inflammatory Markers and CT Severity Score on Disease Severity of COVID-19 Patients Admitted to ICU at a Tertiary Hospital.J Assoc Physicians India. 2021 Jun;69(6):11-12. J Assoc Physicians India. 2021. PMID: 34472783
-
Diabetes Mellitus and SARS-CoV-2 Infection: Pathophysiologic Mechanisms and Implications in Management.Curr Diabetes Rev. 2021;17(6):e123120189797. doi: 10.2174/1573399817666210101110253. Curr Diabetes Rev. 2021. PMID: 33388022 Review.
-
Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths.J Microbiol Immunol Infect. 2020 Jun;53(3):404-412. doi: 10.1016/j.jmii.2020.02.012. Epub 2020 Mar 4. J Microbiol Immunol Infect. 2020. PMID: 32173241 Free PMC article. Review.
Cited by
-
Patients with Diabetes Experienced More Serious and Protracted Sickness from the COVID-19 Infection: A Prospective Study.Medicina (Kaunas). 2023 Feb 27;59(3):472. doi: 10.3390/medicina59030472. Medicina (Kaunas). 2023. PMID: 36984473 Free PMC article.
-
COVID-19 in cancer patients with diabetes in Pakistan: Clinical features and management.Front Oncol. 2022 Aug 18;12:922579. doi: 10.3389/fonc.2022.922579. eCollection 2022. Front Oncol. 2022. PMID: 36059615 Free PMC article.
-
Diabetes and SARS-CoV-2-Is There a Mutual Connection?Front Cell Dev Biol. 2022 Jun 13;10:913305. doi: 10.3389/fcell.2022.913305. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35769263 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources
Miscellaneous